ARRALYZE®, the Life Science arm of LPKF Laser & Electronics SE, proudly broadcasts the business availability of the CellShepherd®. After a profitable beta-testing part in 2023, this groundbreaking platform is now able to revolutionize cell-based analysis and improvement throughout biomedical and numerous life science fields.
CellShepherd®: Redefining single-cell evaluation
CellShepherd®, developed by ARRALYZE®, responds to the pressing want for superior purposeful cell screening applied sciences in educational and industrial laboratories. It stands out with ARRALYZE’s proprietary nanowell glass arrays, which miniaturize cell-based assays whereas enabling real-time monitoring on the single-cell degree.
This autonomous platform boasts exact shelling out into nanoliter glass wells and helps (co)-culturing beneath climate-controlled, sterile circumstances. Its capabilities lengthen to real-time imaging by a brightfield microscope and three fluorescent channels.
Leveraging superior AI-driven evaluation, CellShepherd® precisely counts and tracks cells, providing important insights into numerous parameters. This innovation guarantees a brand new period in scientific analysis characterised by precision, management, and deep insights.
Assembly market calls for: The ARRALYZE® imaginative and prescient
CellShepherd® is designed to meet the rising demand for applied sciences able to finding out small and huge cell populations on the single-cell degree and isolating goal cells. By adopting a holistic strategy, ARRALYZE® allows clients to uncover particular person traits of heterogeneous cell populations and acquire perception into the kinetics of experiments, monitoring performance at completely different time factors.
This strategy overcomes challenges similar to harsh experiment circumstances, restricted microenvironment management, and difficulties sustaining cell viability.
Key options and advantages
- Proprietary nanowell glass arrays for exact miniaturization of cell-based assays.
- Exact shelling out of cell suspensions with excellent viability.
- Autonomous operation supporting (co)-culturing in a climate-controlled, sterile setting.
- Superior real-time imaging capabilities together with a brightfield microscope and three fluorescent channels.
- AI-driven evaluation for correct cell counting and monitoring.
- Person-friendly interface designed for ease of experiment setup, monitoring, and evaluation.
- Capability to isolate stay cells for downstream processes, enhancing versatility and software scope.
LPKF Laser & Electronics SE, the father or mother firm of ARRALYZE, is a number one supplier of laser-based options for the know-how trade. Based in 1976, the corporate is headquartered in Germany, and is lively worldwide by subsidiaries and representatives. The institution of ARRALYZE as a devoted division signifies LPKF’s dedication to innovation and excellence within the biotechnological sector. LPKF Laser & Electronics SE shares are traded within the Prime Commonplace section of Deutsche Börse (ISIN 0006450000).